Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor State
10/07/2018 A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. ROCHE Registered
09/07/2018 Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory CIM Registered
14/06/2018 Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II BIOCEN Registered
11/06/2018 Usual treatment plus intra-articular application of bioactive formulation for osteoarthritis SSA Registered
05/06/2018 Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II CATALYSIS Registered
30/05/2018 Results of an antimicrobial stewardship program CenQfal Registered
30/05/2018 Treatment for maxillary cysts SSA Registered
18/05/2018 Gastricel-I CIDEM Registered
10/05/2018 Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II CATALYSIS Registered
09/05/2018 Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II CATALYSIS Registered
30/04/2018 Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC) CIM Registered
17/04/2018 Oncoxin-Viusid-Advanced or metastatic ovarian epithelial cancer-Adult women-Phase II CATALYSIS Registered
17/04/2018 Biomarkers of exposition_Uchuva Dorada kmunoz Registered
17/04/2018 Obex® - Overweight and Obese - Adults - Phase III CATALYSIS Registered
07/03/2018 14F7 in chronic B-cell lymphoproliferative syndrome CIM Registered
30/01/2018 Bioequivalence of Trienor CIDEM Registered
22/12/2017 Bioequivalence of Efavirenz CIDEM Registered
29/11/2017 Bioequivalence of Zidovudine CIDEM Registered
28/11/2017 Bioequivalence of Sildenafil CIDEM Registered
28/11/2017 Bioequivalence of Phenytoin CIDEM Registered